Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease
NCT01284049
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Liver Diseases
Interventions
DRUG:
Intralipid 20%®
DRUG:
OMEGAVEN 10%®
Sponsor
Assistance Publique - Hôpitaux de Paris